Pyrido- or pyrimido-6,6- or 6,7-bicyclic derivatives, pharmaceutical preparation based thereon and method of treating diseases

摘要

This invention relates to compounds of formula (I), wherein A, B, D, E, K, G, Z, R3 and R5 are defined as in the specification, and to the pharmaceutically acceptable salts of such compounds. Compounds (I) are corticotropin releasing factor (hormone) CRF (CRH) antagonists.